Welcome to the Divis Labs Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.

Stay informed with the Divis Labs Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

Earnings call Divi’s Laboratories reported Q2 FY25 consolidated revenue of ₹2,444 crore, up 22.5% YoY and 11.2% QoQ. Profit after tax rose to ₹510 crore, up 46.6% YoY. Custom synthesis now contributes ...

Divi’s Laboratories Limited ( ($IN:DIVISLAB) ) has shared an announcement. Divi’s Laboratories Limited has announced that it will close its ...

Shares of Divis Laboratories rose 3 percent to Rs 6,188 on Friday, August 22, after global brokerage Citi turned upbeat on the stock, flagging attractive valuations and sector tailwinds. Citi ...

Divi's Laboratories has attracted bullish sentiment from leading brokerage houses. The company’s strong fundamentals, robust R&D capabilities, and leadership position in Active Pharmaceutical ...

shares of Divis Laboratories moved up by 2.11 percent to Rs 6281.50 in early trade. At 09:50 am, the stock is trading among the top gainers on Nifty Next 50. The company has demonstrated consistent ...

The stock of Divi’s Laboratories (₹6,473.50) has been moving in a long range between ₹5,250 and ₹7,000 in the last one year. Immediate support levels are at ₹6,359 and ₹6,200. Nearest resistances are ...